All In Biotech

Free tool

FAERS Monitor: Lotronex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021107 or its brand name (Lotronex, Alosetron Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

833

Serious

362

43% of reports

Hospitalization

189

Death reported

41

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • constipation128
  • drug ineffective125
  • abdominal pain107
  • diarrhoea107
  • colitis ischaemic65
  • vomiting56
  • nausea54
  • adverse event43
  • abdominal pain upper38
  • gastrointestinal injury35
  • rectal haemorrhage35
  • pain27
  • weight decreased25
  • death23
  • headache23

Reports by year received

View as table
YearReports
2004182
200589
2006112
200749
200823
200917
201023
201117
201231
201317
201417
201531
201637
201758
201827
201912
202016
202120
202218
202310
20247
202515
20265

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,326 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
gastrointestinal injurySignal35332.9240.211,108
colitis ischaemicSignal65245.6194.315,448
rectal haemorrhageSignal3520.614.9634
constipationSignal12814.812.61,653
adverse eventSignal4311.88.8415
abdominal painSignal10711.69.71,039
abdominal pain upperSignal384.73.4107
diarrhoeaSignal1074.23.5264
vomitingSignal563.02.375
drug ineffectiveSignal1252.42.0107
weight decreasedSignal252.31.517
nausea541.71.316
pain271.10.80
headache230.90.60
death230.70.53

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.